We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-5.25%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$578B
AUM Growth
-$88.6B
Cap. Flow
+$4.3B
Cap. Flow %
0.74%
Top 10 Hldgs %
34.17%
Holding
14,706
New
1,657
Increased
4,873
Reduced
6,001
Closed
1,835

Sector Composition

Rank Sector Weight
1 Miscellaneous 91.96%
2 Technology 2.07%
3 Consumer Discretionary 1.49%
4 Financials 1.12%
5 Communication Services 1.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLBTW
12301
DELISTED
Cellebrite DI Ltd. Warrants
CLBTW
$42K ﹤0.01%
33,333
EMKR
12302
DELISTED
Emcore Corp
EMKR
$42K ﹤0.01%
1,143
-591
-34% -$28.3K
DMAC icon
12303
DiaMedica Therapeutics
DMAC
$345M
$41K ﹤0.01%
16,324
+2,259
+16% +$6.41K
LPCN icon
12304
Lipocine
LPCN
$17.9M
$41K ﹤0.01%
1,759
-7,946
-82% -$166K
PRPO icon
12305
CALL
Precipio
PRPO
$51.6M
$41K ﹤0.01%
1,530
-1,150
-43% -$31.9K
TRX icon
12306
TRX Gold Corp
TRX
$377M
$41K ﹤0.01%
130,954
-337,757
-72% -$125K
YRD
12307
CALL
Yiren Digital
YRD
$91.9M
$41K ﹤0.01%
16,300
-300
-2% -$786
BRQS
12308
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
$41K ﹤0.01%
+978
New +$59.8K
SEAC
12309
CALL
DELISTED
Seachange International Inc
SEAC
$41K ﹤0.01%
1,820
-29,695
-94% -$751K
SIOX
12310
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$41K ﹤0.01%
61,733
-48,092
-44% -$40.8K
IVC
12311
PUT
DELISTED
Invacare Corporation
IVC
$41K ﹤0.01%
29,000
-20,100
-41% -$43K
OTIC
12312
DELISTED
Otonomy, Inc.
OTIC
$41K ﹤0.01%
+17,283
New +$36.7K
FBRX icon
12313
Forte Biosciences
FBRX
$40K ﹤0.01%
1,101
-1,743
-61% -$66K
KRRO icon
12314
Korro Bio
KRRO
$190M
$40K ﹤0.01%
+380
New +$72.6K
OPTT icon
12315
PUT
Ocean Power Technologies
OPTT
$46.2M
$40K ﹤0.01%
28,400
-2,400
-8% -$3.06K
REAX icon
12316
Real REMAX Group Inc. Common Stock
REAX
$460M
$40K ﹤0.01%
1,769
-57
-3% -$1.47K
RKDA icon
12317
PUT
Arcadia Biosciences
RKDA
$1.28M
$40K ﹤0.01%
721
+180
+33% +$8.59K
RNAC icon
12318
CALL
Cartesian Therapeutics
RNAC
$290M
$40K ﹤0.01%
1,073
-924
-46% -$57.8K
SCOR icon
12319
Comscore
SCOR
$78.4M
$40K ﹤0.01%
687
-1,064
-61% -$61K
SQFT icon
12320
PUT
Presidio Property Trust
SQFT
$2.17M
$40K ﹤0.01%
1,080
UAMY icon
12321
PUT
United States Antimony
UAMY
$726M
$40K ﹤0.01%
60,800
-23,200
-28% -$11.3K
CYTO
12322
DELISTED
Altamira Therapeutics Ltd
CYTO
$40K ﹤0.01%
92
-66
-42% -$31.9K
VISL
12323
CALL
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$40K ﹤0.01%
1,870
+1,275
+214% +$25.8K
YDKG
12324
Yueda Digital Holding
YDKG
$5.49M
$39K ﹤0.01%
57
-81
-59% -$49.1K
BBAI.WS icon
12325
BigBear.ai Holdings Warrant
BBAI.WS
$18.8M
$39K ﹤0.01%
43,914
-11,517
-21% -$9.55K

Similar funds

Jeff Yass's Q1 2022 Portfolio in Review

As of Q1 2022, Jeff Yass held 14,706 positions worth $578B, down 13% from $667B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jeff Yass's Q1 2022 filing shows 1,657 new, 4,873 increased, 6,001 reduced and 1,835 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M. The largest sale was Walt Disney, an estimated $498M.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, down from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q1 2022 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,089,723 shares worth $107M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.98B increase.
  • Jeff Yass's biggest Q1 2022 reduction was Walt Disney, cutting an estimated $498M.
  • Jeff Yass fully exited Xilinx Inc in Q1 2022, selling an estimated $217M.
  • Jeff Yass's ten largest holdings make up 34% of its $578B portfolio in Q1 2022.
  • Jeff Yass opened 1,657 new positions and closed 1,835 in Q1 2022.
  • Jeff Yass's portfolio value fell 13% quarter-over-quarter to $578B.

Based on Susquehanna International Group's 13F filing for Q1 2022, filed 16 May 2022.